196 related articles for article (PubMed ID: 28717596)
1. Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid-enriched CSCs with comparison of MCF-7 microRNA profiling dataset.
Boo L; Ho WY; Mohd Ali N; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Cheong SK; Ong HK
PeerJ; 2017; 5():e3551. PubMed ID: 28717596
[TBL] [Abstract][Full Text] [Related]
2. MiRNA Transcriptome Profiling of Spheroid-Enriched Cells with Cancer Stem Cell Properties in Human Breast MCF-7 Cell Line.
Boo L; Ho WY; Ali NM; Yeap SK; Ky H; Chan KG; Yin WF; Satharasinghe DA; Liew WC; Tan SW; Ong HK; Cheong SK
Int J Biol Sci; 2016; 12(4):427-45. PubMed ID: 27019627
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and microRNA characterization of the neglected CD24+ cell population in MCF-7 breast cancer 3-dimensional spheroid culture.
Boo L; Yeap SK; Ali NM; Ho WY; Ky H; Satharasinghe DA; Liew WC; Tan SW; Wang ML; Cheong SK; Ong HK
J Chin Med Assoc; 2020 Jan; 83(1):67-76. PubMed ID: 31904742
[TBL] [Abstract][Full Text] [Related]
4. Exosomal-microRNA transcriptome profiling of Parental and CSC-like MDA-MB-231 cells in response to cisplatin treatment.
Koh MZ; Ho WY; Yeap SK; Ali NM; Yong CY; Boo L; Alitheen NB
Pathol Res Pract; 2022 May; 233():153854. PubMed ID: 35398617
[TBL] [Abstract][Full Text] [Related]
5. Amino acid profile changes during enrichment of spheroid cells with cancer stem cell properties in MCF-7 and MDA-MB-231 cell lines.
Ghanbari Movahed Z; Matin MM; Mansouri K; Sisakhtnezhad S
Cancer Rep (Hoboken); 2023 May; 6(5):e1809. PubMed ID: 37092500
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-3646 Contributes to Docetaxel Resistance in Human Breast Cancer Cells by GSK-3β/β-Catenin Signaling Pathway.
Zhang X; Zhong S; Xu Y; Yu D; Ma T; Chen L; Zhao Y; Chen X; Yang S; Wu Y; Tang J; Zhao J
PLoS One; 2016; 11(4):e0153194. PubMed ID: 27045586
[TBL] [Abstract][Full Text] [Related]
7. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression.
Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W
Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle Delivery of miR-34a Eradicates Long-term-cultured Breast Cancer Stem Cells via Targeting C22ORF28 Directly.
Lin X; Chen W; Wei F; Zhou BP; Hung MC; Xie X
Theranostics; 2017; 7(19):4805-4824. PubMed ID: 29187905
[No Abstract] [Full Text] [Related]
10. miRNA-34a is associated with docetaxel resistance in human breast cancer cells.
Kastl L; Brown I; Schofield AC
Breast Cancer Res Treat; 2012 Jan; 131(2):445-54. PubMed ID: 21399894
[TBL] [Abstract][Full Text] [Related]
11. Eribulin upregulates miR-195 expression and downregulates Wnt3a expression in non-basal-like type of triple-negative breast cancer cell MDA-MB-231.
Furuya K; Sasaki A; Tsunoda Y; Tsuji M; Udaka Y; Oyamada H; Tsuchiya H; Oguchi K
Hum Cell; 2016 Apr; 29(2):76-82. PubMed ID: 26573286
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
13. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
15. Bioinformatics identification of dysregulated microRNAs in triple negative breast cancer based on microRNA expression profiling.
Chen J; Chen Z; Huang J; Chen F; Ye W; Ding G; Wang X
Oncol Lett; 2018 Mar; 15(3):3017-3023. PubMed ID: 29435032
[TBL] [Abstract][Full Text] [Related]
16. Down-Regulation of miR-200c and Up-Regulation of miR-30c Target both Stemness and Metastasis Genes in Breast Cancer.
Rahimi M; Sharifi-Zarchi A; Zarghami N; Geranpayeh L; Ebrahimi M; Alizadeh E
Cell J; 2020 Jan; 21(4):467-478. PubMed ID: 31376329
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profile of gastric cancer stem cells in the MKN-45 cancer cell line.
Liu J; Ma L; Wang Z; Wang L; Liu C; Chen R; Zhang J
Acta Biochim Biophys Sin (Shanghai); 2014 Feb; 46(2):92-9. PubMed ID: 24384510
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA Regulation of Human Breast Cancer Stem Cells.
Shimono Y; Mukohyama J; Nakamura S; Minami H
J Clin Med; 2015 Dec; 5(1):. PubMed ID: 26712794
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells.
Browne G; Dragon JA; Hong D; Messier TL; Gordon JA; Farina NH; Boyd JR; VanOudenhove JJ; Perez AW; Zaidi SK; Stein JL; Stein GS; Lian JB
Tumour Biol; 2016 Jul; 37(7):8825-39. PubMed ID: 26749280
[TBL] [Abstract][Full Text] [Related]
20. Differential microRNA expression profiles determined by next-generation sequencing in three fulvestrant-resistant human breast cancer cell lines.
Guo J; He K; Zeng H; Shi Y; Ye P; Zhou Q; Pan Z; Long X
Oncol Lett; 2019 Apr; 17(4):3765-3776. PubMed ID: 30930984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
